MassDevice.com +5 | The top 5 medtech stories for June 6, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Report: Valeant shopping sale of surgical eye biz Valeant Pharmaceuticals is looking to sell its Bausch & Lomb division’s surgical product assets to Carl Zeiss Meditec, according to a Bloomberg report. The surgical eye assets could be worth approximately $2 billion, according to the report, with a possible agreement still weeks away. Read more 4. FDA lifts warning letter on Masimo plant in California Masimo said today that the FDA lifted a 2014 warning letter issued over procedures at the Irvine, Calif., plant that makes its Pronto 7 pulse oximeters. The federal safety watchdog sent the letter in August 2014 after inspections in August to October 2013, flagging Masimo for failing to “review, evaluate, and investigate complaints involving the possible failure of a device to meet any of its specifications,” citing customer complaints “regarding inaccurate readings of the Pronto 7 devices.” Read more 3. Apple Watch to gain direct support for Dexcom G5 glucose sensor Dexcom and Apple will team up to integrate data directly from Dexcom’s glucose sensors ...
Source: Mass Device - Category: Medical Devices Authors: Tags: News Well Plus 5 Source Type: news